Brasil Pharma Starts Roadshow
Brasil Pharma was to begin Monday meeting with investors ahead of a BRL250m ($110m) domestic bond sale, according to a prospectus. The...
Already have an account?
Subscribe now for unlimited access to all current and archive news, data and market analysis.
Take a free two-week trial now for the latest news, data and market analysis.